Viewing StudyNCT06315556

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06315556
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2024-02-26
Brief Title: An Observational Study to Collect Data on How Aflibercept Eylea Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom UK
Sponsor: Bayer
Organization: Bayer
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Preterm Infants
Retinopathy of Prematurity
Keywords:
Name View
ROP View